Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Xing Dai

Showing results (351-360 of 354) with videos related to

Pageof 36
Sort By:
You have reached the last page of results.This site can display upto 354 results.
Journal of Medicinal Chemistry|February 18, 2014
The discovery of N-((2H-tetrazol-5-yl)methyl)-4-((R)-1-((5r,8R)-8-(tert-butyl)-3-(3,5-dichlorophenyl)-2-oxo-1,4-diazaspiro[4.5]dec-3-en-1-yl)-4,4-dimethylpentyl)benzamide (SCH 900822): a potent and selective glucagon receptor antagonistDuane DeMong, Xing Dai, Joyce Hwa, et al.
Scientific Reports|July 20, 2016
Prevalence of Atopic Dermatitis in Chinese Children aged 1-7 ysYifeng Guo, Ping Li, Jianping Tang, et al.
Journal of Medicinal Chemistry|March 1, 2017
Discovery of a 3-(4-Pyrimidinyl) Indazole (MLi-2), an Orally Available and Selective Leucine-Rich Repeat Kinase 2 (LRRK2) Inhibitor that Reduces Brain Kinase ActivityJack D Scott, Duane E DeMong, Thomas J Greshock, et al.
Nature Genetics|June 14, 2011
Genome-wide association study identifies two new susceptibility loci for atopic dermatitis in the Chinese Han populationLiang-Dan Sun, Feng-Li Xiao, Yang Li, et al.
Pageof 36

Showing results (351-360 of 354) with videos related to

Sort By:
Pageof 36
You have reached the last page of results.This site can display upto 354 results.
Journal of Medicinal Chemistry|February 18, 2014
The discovery of N-((2H-tetrazol-5-yl)methyl)-4-((R)-1-((5r,8R)-8-(tert-butyl)-3-(3,5-dichlorophenyl)-2-oxo-1,4-diazaspiro[4.5]dec-3-en-1-yl)-4,4-dimethylpentyl)benzamide (SCH 900822): a potent and selective glucagon receptor antagonistDuane DeMong, Xing Dai, Joyce Hwa, et al.
Scientific Reports|July 20, 2016
Prevalence of Atopic Dermatitis in Chinese Children aged 1-7 ysYifeng Guo, Ping Li, Jianping Tang, et al.
Journal of Medicinal Chemistry|March 1, 2017
Discovery of a 3-(4-Pyrimidinyl) Indazole (MLi-2), an Orally Available and Selective Leucine-Rich Repeat Kinase 2 (LRRK2) Inhibitor that Reduces Brain Kinase ActivityJack D Scott, Duane E DeMong, Thomas J Greshock, et al.
Nature Genetics|June 14, 2011
Genome-wide association study identifies two new susceptibility loci for atopic dermatitis in the Chinese Han populationLiang-Dan Sun, Feng-Li Xiao, Yang Li, et al.
Pageof 36